QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 296 filers reported holding QIAGEN NV in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,605 | +0.1% | 89 | +11.2% | 0.00% | – |
| Q2 2023 | $3,602 | -59.6% | 80 | -58.8% | 0.00% | – |
| Q1 2023 | $8,910 | +16.8% | 194 | +26.8% | 0.00% | – |
| Q4 2022 | $7,630 | +281.5% | 153 | +200.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 51 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -60.0% | 51 | -48.0% | 0.00% | – |
| Q4 2021 | $5,000 | +400.0% | 98 | +237.9% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 29 | -12.1% | 0.00% | – |
| Q4 2020 | $2,000 | – | 33 | +725.0% | 0.00% | – |
| Q3 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 4 | -87.9% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 33 | -42.1% | 0.00% | – |
| Q4 2019 | $2,000 | -77.8% | 57 | -78.9% | 0.00% | – |
| Q3 2019 | $9,000 | +350.0% | 270 | +373.7% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | – | 57 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
| Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
| Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
| Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
| SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
| SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
| Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
| Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
| Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |